This was the stock's third consecutive day of losses.

The pet care industry is growing, providing IDEXX with significant growth opportunities. Check out why I rate IDXX stock as a ...

IDEXX Laboratories posted fourth-quarter 2024 ... The gross margin expanded 144 basis points (bps) to 59.8% despite a 2.2% rise in the cost of revenues. Sales and marketing expenses rose 5.7% ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

IDEXX Laboratories, Inc. IDXX posted fourth-quarter ... The gross margin expanded 144 basis points (bps) to 59.8% despite a 2.2% rise in the cost of revenues. Sales and marketing expenses rose ...

Idexx Laboratories (IDXX) came out with quarterly earnings of $2.62 per share, beating the Zacks Consensus Estimate of $2.40 per share. This compares to earnings of $2.32 per share a year ago.

Idexx Laboratories exceeded earnings expectations for Q4 2024, buoyed by robust performance in its key diagnostic segments. Idexx Laboratories offers a variety of products and diagnostic services ...